Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2025-12-25 @ 1:45 AM
NCT ID:
NCT03563794
Eligibility Criteria:
Inclusion Criteria:
* T2DM
* 30≤ age≤70 years old
* BMI 18.0-28.0 Kg/m2
* HbA1c ≥8.5%
* Negtive GAD、ICA、IAA
* Patients do not use antihyperglycemia drugs
* Patients use antihyperglycemia drugs for ≥8 weeks(exclusion of DPP-4 inhibitors and GLP-1 receptor agonist)
Exclusion Criteria:
* T1DM,GDM
* Congestive heart failure (New York Heart Association Functional Classification III-IV)
* ALT or AST\> 2 times above normal,GFR \<50ml/min
* Severe infection in the previous 3 months
* Severely acute or chronic diabetic complications
* Patients who were taking medications,known to affect glycaemic control, such as glucocorticoids(aside from antidiabetic medications)
* History of pancreatitis
* Trauma or patients operating at a scheduled time
* Any mental health condition
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
30 Years
Maximum Age:
70 Years
Study:
NCT03563794
Study Brief:
Protocol Section:
NCT03563794